Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J. +7 more·2016·Nature Communications
Cited by (1,003)
Items 301–400 of 1,003
- Immune regulation by monocytesPeter J. Murray · 2017 · Seminars in Immunology
- Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effectsTakenori Uehara, Shingo Eikawa, Mikako Nishida, Yuki Kunisada, Aki Yoshida, Tomohiro Fujiwara, Toshiyuki Kunisada, Toshifumi Ozaki, Heiichiro Udono · 2018 · International Immunology
- The Generation and Identity of Human Myeloid-Derived Suppressor CellsCaroline Bergenfelz, Karin Leandersson · 2020 · Frontiers in Oncology
- The Contribution of the Immune System in Bone Metastasis PathogenesisLisha Xiang, Daniele M. Gilkes · 2019 · International Journal of Molecular Sciences
- Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myelomaMuthulekha Swamydas, Elena V. Murphy, James John Ignatz-Hoover, Ehsan Malek, James Joseph Driscoll · 2022 · Journal of Hematology & Oncology
- The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive reviewToufik Abdul‐Rahman, Shankhaneel Ghosh, Sarah M. Badar, Abubakar Nazir, Gafar Babatunde Bamigbade, Narjiss Aji, Poulami Roy, Hajar kachani, Neil K. Garg, Lukman Lawal et al. · 2024 · European journal of medical research
- Leukocyte trafficking in tumor microenvironmentAnnalisa Del Prete, Tiziana Schioppa, Laura Tiberio, Helena Stabile, Silvano Sozzani · 2017 · Current Opinion in Pharmacology
- Myeloid-derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapyJason Alan Chesney, Robert A. Mitchell, Kavitha Yaddanapudi · 2017 · Journal of Leukocyte Biology
- Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and ModulationScott J. Denstaedt, Benjamin H. Singer, Theodore J. Standiford · 2018 · Frontiers in Immunology
- Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severitySara Falck‐Jones, Sindhu Vangeti, Meng Yu, Ryan Falck‐Jones, Alberto Cagigi, Isabella Badolati, Björn Österberg, Maximilian Julius Lautenbach, Eric Åhlberg, Ang Lin et al. · 2021 · Journal of Clinical Investigation
- Overcoming cold tumors: a combination strategy of immune checkpoint inhibitorsPeng Ouyang, Lijuan Wang, Jianlong Wu, Yao Tian, Caiyun Chen, Dengsheng Li, Zengxi Yao, Ruichang Chen, Guoan Xiang, Jin Gong et al. · 2024 · Frontiers in Immunology
- Myeloid derived-suppressor cells: their role in cancer and obesitySuzanne Ostrand‐Rosenberg · 2018 · Current Opinion in Immunology
- Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cellsDavid M. Peereboom, Tyler Joseph Alban, Matthew M. Grabowski, Alvaro G. Alvarado, Balint Otvos, Defne Bayık, Gustavo A. Roversi, Mary McGraw, Pengjing Huang, Alireza Mohammad Mohammadi et al. · 2019 · JCI Insight
- Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patientsLiangliang Wu, Zhaoyang Deng, Yaojun Peng, Lu Han, Jing Liu, Linxiong Wang, Bohua Li, Jian Zhao, Shunchang Jiao, Huafeng Wei · 2017 · Oncotarget
- Endoplasmic reticulum stress induced LOX‐1+ CD 15+ polymorphonuclear myeloid‐derived suppressor cells in hepatocellular carcinomaJiang Nan, Yan‐Fang Xing, Bo Hu, Jian‐Xin Tang, Huimin Dong, Yu‐Mei He, Dan‐Yun Ruan, Qing‐Jian Ye, Jia‐Rong Cai, Xiaokun Ma et al. · 2017 · Immunology
- Role of Tumor-Associated Myeloid Cells in Breast CancerYoon Jin Cha, Ja Seung Koo · 2020 · Cells
- Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapyChia-Hsin Liu, Zhong Chen, Kong Chen, Fu-Tien Liao, Chia-En Chung, Xiao-Ping Liu, Yu-Chun Lin, P. Keohavong, G. Leikauf, Y. Di · 2020 · Cancer Research
- PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironmentNatalie Bucheimer Collins, Rose Al Abosy, Brian C. Miller, Kevin Bi, Qihong Zhao, Michael M. Quigley, Jeffrey Joseph Ishizuka, Kathleen B. Yates, Hans W. Pope, Robert T. Manguso et al. · 2022 · Journal for ImmunoTherapy of Cancer
- Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedsideYue Yin, Weibo Feng, Jie Chen, Xilang Chen, Guodong Wang, Shuai Wang, Xiao Xu, Yongzhan Nie, Daiming Fan, Kaichun Wu et al. · 2024 · Experimental Hematology and Oncology
- Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcomeAlessandra Sacchi, Germana Grassi, Veronica Bordoni, Patrizia Lorenzini, Eleonora Cimini, Rita Casetti, Eleonora Tartaglia, Luisa Marchioni, Nicola Petrosillo, Fabrizio Palmieri et al. · 2020 · Cell Death and Disease
- Multicenter Systems Analysis of Human Blood Reveals Immature Neutrophils in Males and During PregnancyJana Blažková, Sarthak Gupta, Yudong Liu, Brice L Gaudilliere, Edward A. Ganio, Christopher R. Bolen, Ron Saar Dover, Gabriela K. Fragiadakis, Martin S. Angst, Sarfaraz Hasni et al. · 2017 · The Journal of Immunology
- Neutrophils in COVID-19: Not Innocent BystandersEllen McKenna, Richard Wubben, Johana M. Isaza-Correa, Ashanty M. Melo, Aisling Ui Mhaonaigh, Niall P. Conlon, James S. O’Donnell, Clíona Ní Cheallaigh, Tim Hurley, Nigel J. Stevenson et al. · 2022 · Frontiers in Immunology
- Anti‐PD‐1/PD‐L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancerV. Gunda, B. Gigliotti, Tameem Ashry, Dorothy Ndishabandi, M. McCarthy, Zhiheng Zhou, S. Amin, Kyu Eun Lee, T. Stork, L. Wirth et al. · 2019 · International Journal of Cancer
- c-Rel is a myeloid checkpoint for cancer immunotherapyTing Li, Xinyuan Li, Ali Zamani, Wei Wang, Chin‐Nien Lee, Mingyue Li, George Luo, Emily Eiler, Honghong Sun, Sankar Ghosh et al. · 2020 · Nature Cancer
- Long noncoding RNA: a dazzling dancer in tumor immune microenvironmentYalu Zhang, Qiaofei Liu, Quan Liao · 2020 · Journal of Experimental & Clinical Cancer Research
- Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlasYi Wang, Qing Sun, Yun Zhang, Xuelian Li, Qingtao Liang, Ru Guo, Li‐Qun Zhang, Xiqin Han, Jing Wang, Lingling Shao et al. · 2023 · Journal of Infection
- Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linkingAlessandro Porrello, Patrick L. Leslie, Emily B. Harrison, Balachandra K. Gorentla, Sravya Kattula, Subrata Kumar Ghosh, Salma H. Azam, Alisha Holtzhausen, Yvonne L. Chao, Michele C. Hayward et al. · 2018 · Nature Communications
- Myeloid-Derived Suppressor Cells: Ductile Targets in DiseaseFrancesca Maria Consonni, Chiara Porta, Arianna Marino, Chiara Pandolfo, Silvia Mola, Augusto Bleve, Antonio Sica · 2019 · Frontiers in Immunology
- Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsisMcKenzie K. Hollen, Julie A. Stortz, Dijoia B. Darden, Marvin L. S. Dirain, Dina C. Nacionales, Russell B. Hawkins, Michael C. Cox, Maria-Cecilia Lopez, Jaimar C. Rincon, Ricardo F. Ungaro et al. · 2019 · Critical Care
- The colorectal cancer immune microenvironment and approach to immunotherapiesMinoru Koi, John M. Carethers · 2017 · Future Oncology
- Myeloid-Derived Suppressor Cells in Colorectal CancerIzabela Siemińska, Jarek Baran · 2020 · Frontiers in Immunology
- Lactate in the tumor microenvironment: A rising star for targeted tumor therapyZhangzuo Li, Qi Wang, Xu‐Feng Huang, Mengting Yang, Shujing Zhou, Zhengrui Li, Zhengzou Fang, Yidan Tang, Qian Chen, Hanjin Hou et al. · 2023 · Frontiers in Nutrition
- Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell ActivitySabina Sangaletti, Claudio Tripodo, Alessandra Santangelo, Nadia Castioni, Paola Portararo, Alessandro Gulino, Laura Botti, Mariella Parenza, Barbara Cappetti, Rosaria Orlandi et al. · 2016 · Cell Reports
- Perturbation of the Monocyte Compartment in Human ObesityKathleen Friedrich, Miriam Sommer, Sarah Strobel, Stephan Thrum, Matthias Blüher, Ulf G. Wagner, Manuela Rossol · 2019 · Frontiers in Immunology
- Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanismsGanping Wang, Ming Zhang, Maosheng Cheng, Xiaochen Wang, Kang Li, Jianwen Chen, Zhi Chen, Shuang Chen, Jie Chen, Gan Xiong et al. · 2021 · Cancer Letters
- Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic targetFeyza Gül Özbay Kurt, Samantha Lasser, Ihor Arkhypov, Jochen Sven Utikal, Viktor Umansky · 2023 · Journal of Clinical Investigation
- Targeting myeloid-derived suppressor cells for cancer immunotherapyYijun Liu, Guo‐Wei Wei, Wesley A. Cheng, Zhenyuan Dong, Han Sun, Vincent Y. Lee, Soung-chul Cha, Diane Lynne Smith, Larry W. Kwak, Hong Qin · 2018 · Cancer Immunology Immunotherapy
- Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target?Mahnaz Janghorban, Li Xin, Jeffrey M. Rosen, Xiang H.-F. Zhang · 2018 · Frontiers in Immunology
- CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cellsDavid K. Edwards V, Kevin Watanabe‐Smith, Angela Rofelty, Alisa Damnernsawad, Ted Laderas, Adam J. Lamble, Evan F. Lind, Andy J. Kaempf, Motomi Mori, Mara W. Rosenberg et al. · 2018 · Blood
- Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in CancerPeiwen Ma, Pamela L. Beatty, John McKolanis, Randal E. Brand, Robert E. Schoen, Olivera J. Finn · 2019 · Frontiers in Immunology
- ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progressionNi Li, Qiuli Liu, Ying Han, Siyu Pei, Bisheng Cheng, Junyu Xu, Xiang Miao, Qiang Pan‐Hammarström, Hanling Wang, Jiacheng Guo et al. · 2022 · Nature Communications
- Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinomaLi, Meiyi, Wang, Lina, Cong, Liang, Wong, Chi Chun, Zhang, Xiang, Chen, Huarong, Zeng, Tao, Li, Bin, Jia, Xian, Huo, Jihui et al. · 2024 · Hepatology
- Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLCTang, Kwan Ho, Li, Shuai, Khodadadi-Jamayran, Alireza, Jen, Jayu, Han, Han, Guidry, Kayla, Chen, Ting, Hao, Yuan, Fedele, Carmine, Zebala, John A. et al. · 2022 · Cancer Discovery
- Myeloid-derived suppressor cells and their role in pancreatic cancerMatthew Pergamo, George Miller · 2016 · Cancer Gene Therapy
- An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019Veronica Bordoni, Alessandra Sacchi, Eleonora Cimini, Stefania Notari, Germana Grassi, Eleonora Tartaglia, Rita Casetti, Maria Letizia Giancola, Nazario Bevilacqua, Markus J. Maeurer et al. · 2020 · Clinical Infectious Diseases
- A Milestone Review on How Macrophages Affect Tumor GrowthChristophe Caux, Rodrigo Nalio Ramos, George C. Prendergast, Nathalie Bendriss‐Vermare, Christine Ménétrier‐Caux · 2016 · Cancer Research
- Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancerJing Chen, Hong-Wei Sun, Yanyan Yang, Haitian Chen, Xing-Juan Yu, Wenchao Wu, Yi-Tuo Xu, Li-Lian Jin, Xiaojun Wu, Jing Xu et al. · 2021 · Signal Transduction and Targeted Therapy
- Myeloid-Derived Suppressor Cells in Solid TumorsTianmiao Ma, Bernhard Willibald Renz, Matthias Ilmer, Dominik Thomas Koch, Yuhui Yang, Jens Werner, Alexandr V. Bazhin · 2022 · Cells
- Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal–fetal tolerance in miceSuzanne Ostrand‐Rosenberg, Pratima Sinha, Chas Figley, Ramses Long, DoHwan Park, Darryl Carter, Virginia K. Clements · 2016 · Journal of Leukocyte Biology
- Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CMLOscar E. Brück, Sami Blom, Olli Dufva, Riku Turkki, Himanshu Chheda, Antonio Ribeiro, Panu E. Kovanen, Tero A. Aittokallio, Perttu Koskenvesa, Olli Kallioniemi et al. · 2018 · Leukemia
- Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathwayWanwei Zheng, Huan Song, Zhongguang Luo, Hao Wu, Lin Chen, Yuedi Wang, Haoshu Cui, Yufei Zhang, Bangting Wang, Wenshuai Li et al. · 2021 · Proceedings of the National Academy of Sciences
- Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell SubsetsSergej Tomić, Bojan Joksimović, Marina Bekić, Miloš Vasiljević, Marijana Milanović, Miodrag J Čolić, Dragana Vučević · 2019 · Frontiers in Immunology
- The role of myeloid-derived suppressor cells (MDSC) in the inflammaging processAntero Salminen, Kai Kaarniranta, Anu Kauppinen · 2018 · Ageing Research Reviews
- Role of Tumor-Mediated Dendritic Cell Tolerization in Immune EvasionNicholas C. DeVito, Michael P. Plebanek, Bala Theivanthiran, Brent Allen Hanks · 2019 · Frontiers in Immunology
- The Tumor Immune Microenvironment in Clear Cell Renal Cell CarcinomaCésar U. Monjarás-Ávila, Ana C. Lorenzo‐Leal, Ana Cecilia Luque-Badillo, Ninadh Malrina D’Costa, Claudia I. Chavez-Munoz, Horacio Bach · 2023 · International Journal of Molecular Sciences
- Myeloid‐derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapyZhongnan Yin, Chunxiao Li, Junjie Wang, Lixiang Xue · 2018 · International Journal of Cancer
- The Pseudogene Olfr29-ps1 Promotes the Suppressive Function and Differentiation of Monocytic MDSCsWencong Shang, Yunhuan Gao, Zhenzhen Tang, Yuan Zhang, Rongcun Yang · 2019 · Cancer Immunology Research
- Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitorBrendan D. Curti, Yoshinobu Koguchi, Rom S. Leidner, Annah S. Rolig, Elizabeth R. Sturgill, Zhaoyu Sun, Yaping Wu, Venkatesh Rajamanickam, Brady M. Bernard, Ian Hilgart-Martiszus et al. · 2021 · Journal for ImmunoTherapy of Cancer
- GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcomeSilvia Tiberti, Carlotta Catozzi, Ottavio Croci, Mattia Ballerini, Danilo Cagnina, Chiara Soriani, Caterina Scirgolea, Zheng Gong, Jia-Tai He, Angeli D.G. Macandog et al. · 2022 · Nature Communications
- Immune cells as tumor drug delivery vehiclesFrancis Combes, Evelyne Meyer, Niek N. Sanders · 2020 · Journal of Controlled Release
- Reconstitution of T Cell Proliferation under Arginine Limitation: Activated Human T Cells Take Up Citrulline via L-Type Amino Acid Transporter 1 and Use It to Regenerate Arginine after Induction of Argininosuccinate Synthase ExpressionAnke Werner, Miriam Koschke, Nadine Leuchtner, Claudia Luckner‐Minden, Alice Habermeier, Johanna Rupp, Christin Heinrich, Roland Conradi, Ellen Ildicho Closs, Markus Munder · 2017 · Frontiers in Immunology
- Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphomaStefania Orecchioni, Giovanna Talarico, Valentina Labanca, Angelica Calleri, Patrizia Mancuso, Francesco Bertolini · 2018 · British Journal of Cancer
- Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel DiseaseCindy Barnig, Tjitske Bezema, Philip C. Calder, Anne Charloux, Nelly Frossard, Johan Garssen, Oliver Haworth, Ksenia Dilevskaya, Francesca Levi‐Schaffer, Evelyne Lonsdorfer‐Wolf et al. · 2019 · Frontiers in Immunology
- Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the CrossroadAugusto Bleve, Barbara Durante, Antonio Sica, Francesca Maria Consonni · 2020 · International Journal of Molecular Sciences
- 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progressionMa, Liqian, Wang, Lawrence, Nelson, Adam T., Han, Chaeyeon, He, Sisi, Henn, Madeline A., Menon, Karan, Chen, Joy J., Baek, Amy E., Vardanyan, Anna et al. · 2020 · Cancer Letters
- Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic MelanomaRichard P. Tobin, Dasha T. Cogswell, Victoria M. Cates, Dana M. Davis, Jessica S.W. Borgers, Robert J. Van Gulick, Elizabeth N. Katsnelson, Kasey L. Couts, Kimberly Rae Jordan, Dexiang Gao et al. · 2022 · Clinical Cancer Research
- Targeting the Tumor Microenvironment of Leukemia and LymphomaUta E. Höpken, Armin Rehm · 2019 · Trends in cancer
- Notch-mediated lactate metabolism regulates MDSC development through the Hes1/MCT2/c-Jun axis.Jun-Long Zhao, Yuchen Ye, Chun-Chen Gao, Liang Wang, Kaikai Ren, Ru Jiang, Si-Jun Hu, Shi-Qian Liang, Jian Bai, Jia-Long Liang et al. · 2022 · Cell Reports
- Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrowRoussel, Mikael, Ferrell, P Brent, Greenplate, Allison R, Lhomme, Faustine, Le Gallou, Simon, Diggins, Kirsten E, Johnson, Douglas B, Irish, Jonathan M · 2017 · Journal of Leukocyte Biology
- Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian CancerKarolina Okła, Arkadiusz Czerwonka, Anna Wawruszak, Marcin Stanisław Bobiński, Monika Bilska, Rafał Tarkowski, Wiesława Bednarek, Iwona Wertel, Jan Kotarski · 2019 · Frontiers in Immunology
- Autophagy, the innate immune response and cancerChelsea Gerada, Kevin M. Ryan · 2020 · Molecular Oncology
- Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New ProspectsTianhang Li, Tianyao Liu, Wenjie Zhu, Shangxun Xie, Zihan Zhao, Baofu Feng, Hongqian Guo, Rong Yang · 2021 · Clinical Medicine Insights Oncology
- CD8 + T cell exhaustion in anti‐tumour immunity: The new insights for cancer immunotherapyYijin Huang, Anna Jia, Yufei Wang, Guangwei Liu · 2022 · Immunology
- The Endless Saga of Monocyte DiversityStefania Canè, Stefano Ugel, Rosalinda Trovato, Ilaria Marigo, Francesco De Sanctis, Silvia Sartoris, Vincenzo Bronte · 2019 · Frontiers in Immunology
- Monocyte metabolic reprogramming promotes pro-inflammatory activity and Staphylococcus aureus biofilm clearanceKelsey J. Yamada, Cortney E. Heim, Xinyuan Xi, Kuldeep Singh Attri, Dezhen Wang, Wenting Zhang, Pankaj K. Singh, Tatiana K. Bronich, Tammy Kielian · 2020 · PLoS Pathogens
- Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer ImmunotherapyCristina Zalfa, Silke Paust · 2021 · Frontiers in Immunology
- The Key Role of Exosomes on the Pre-metastatic Niche Formation in TumorsXuyang Yang, Yang Zhang, Yaguang Zhang, Su Zhang, Lei Qiu, Zixuan Zhuang, Mingtian Wei, Xiangbing Deng, Ziqiang Wang, Junhong Han · 2021 · Frontiers in Molecular Biosciences
- G-CSF, the guardian of granulopoiesisHrishikesh Mehta, Seth Joel Corey · 2021 · Seminars in Immunology
- Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitmentVickman, Renee E., Broman, Meaghan M., Lanman, Nadia A., Franco, Omar E., Sudyanti, Putu Ayu G., Ni, Yang, Ji, Yuan, Helfand, Brian T., Petkewicz, Jacqueline, Paterakos, Michael C. et al. · 2020 · The Prostate
- Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicityTai, Lee-Hwa, Alkayyal, Almohanad A., Leslie, Amanda L., Sahi, Shalini, Bennett, Sean, Tanese de Souza, Christiano, Baxter, Katherine, Angka, Leonard, Xu, Rebecca, Kennedy, Michael A. et al. · 2018 · OncoImmunology
- Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)Jessica C. Hassel, Huanhuan Jiang, Carolin Bender, Julia Katharina Winkler, Alexandra Sevko, Ivan Shevchenko, Niels Halama, Antonia Dimitrakopoulou‐Strauss, Walter E. Haefeli, Dirk Jäger et al. · 2017 · OncoImmunology
- A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell TherapyRebecca Epperly, Stephen M Gottschalk, Mireya Paulina Velasquez · 2020 · Frontiers in Oncology
- Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment ResistanceSabbir Khan, Sandeep Mittal, Kain McGee, Kristin D. Alfaro-Munoz, Nazanin Majd, Veerakumar Balasubramaniyan, John de Groot · 2020 · International Journal of Molecular Sciences
- Landscape of Myeloid-derived Suppressor Cell in Tumor ImmunotherapyZhaonian Hao, Ruyuan Li, Yuanyuan Wang, Shuangying Li, Zhenya Hong, Zhiqiang Han · 2021 · Biomarker Research
- Advances in Immune Monitoring Approaches for Sepsis-Induced ImmunosuppressionRen-qi Yao, Chao Ren, Liyu Zheng, Zhaofan Xia, Yong-ming Yao · 2022 · Frontiers in Immunology
- SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responsesAnthos Christofides, Xanthi-Lida Katopodi, Carol Cao, Dimitra Karagkouni, Konstantinos Aliazis, Sasitorn Yenyuwadee, Halil‐Ibrahim Aksoylar, Rinku Pal, Mohamed A. A. Mahmoud, Laura Strauss et al. · 2022 · Nature Immunology
- Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitisCantoni, Claudia, Cignarella, Francesca, Ghezzi, Laura, Mikesell, Bob, Bollman, Bryan, Berrien-Elliott, Melissa M., Ireland, Aaron R., Fehniger, Todd A., Wu, Gregory F., Piccio, Laura · 2017 · Acta Neuropathologica
- Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor CellsChorong Lee, Wongeun Lee, Steve K. Cho, Sung‐Gyoo Park · 2018 · International Journal of Molecular Sciences
- The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte inductionBenjamin T. Himes, Timothy E. Peterson, Tristan de Mooij, Luz Milbeth Cumba Garcia, Mi-Yeon Jung, Sarah A. Uhm, David Z. Yan, Jasmine Tyson, Helen J. Jin‐Lee, Daniel Parney et al. · 2020 · Neuro-Oncology
- Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancerLi Xiao, Ulrike Erb, Kun Zhao, Thilo Hackert, Margot Zöller · 2017 · OncoImmunology
- Aurora A inhibition eliminates myeloid cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in breast cancerYin, Tingting, Zhao, Zhi-Bin, Guo, Jing, Wang, Tianchen, Yang, Jing-Bo, Wang, Chao, Long, Jie, Ma, Shisong, Huang, Qiang, Zhang, Kaiguang et al. · 2019 · Cancer Research
- Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and ImmunotherapyMithunah Krishnamoorthy, Lara Gerhardt, Saman Maleki Vareki · 2021 · Cells
- Targeting tumour-intrinsic N 7 -methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacyHai‐Ning Liu, Xuezhen Zeng, Xuxin Ren, Yifan Zhang, Manling Huang, Li Tan, Zihao Dai, Jiaming Lai, Wenxuan Xie, Zebin Chen et al. · 2022 · Gut
- Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockadeHaoran Zha, Xiao Han, Ying Jie Zhu, Fei Yang, Yongsheng Li, Qijing Li, Bo Guo, Bo Zhu · 2017 · OncoImmunology
- CCR5 Directs the Mobilization of CD11b+Gr1+Ly6Clow Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor DevelopmentElias Hawila, Hila Razon, Gizi Wildbaum, C Blattner, Yair Sapir, Yuval Shaked, Viktor Umansky, N Karin · 2017 · Cell Reports
- IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor CellsWei Lie Xiao, John David Klement, Chunwan Lu, Mohammed L. Ibrahim, Kebin Liu · 2018 · The Journal of Immunology
- MDSC subtypes and CD39 expression on CD8 + T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLCJiae Koh, Youjin Kim, Kyoung Young Lee, Joon Young Hur, Mi Soon Kim, Boram Kim, Hee Jin Cho, Yeong Chan Lee, Yeon Hee Bae, Bo Mi Ku et al. · 2020 · European Journal of Immunology
- Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinomaAnna Sosnowska, Justyna Chlebowska, Paweł Matryba, Zofia Pilch, Alan Greig, Artur Wolny, Tomasz M. Grzywa, Zuzanna Rydzyńska, Olga Sokołowska, Tomasz P. Rygiel et al. · 2021 · OncoImmunology
- The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancerJiacheng He, Xiaolei Chai, Qiansen Zhang, Yang Wang, Yijie Wang, Xinyu Yang, Jingbo Wu, Bo Feng, Jing Ping Sun, Weiwei Rui et al. · 2025 · Nature Immunology
- Hedgehog Signaling Links Chronic Inflammation to Gastric Cancer Precursor LesionsJuanita L. Merchant, Lin Ding · 2017 · Cellular and Molecular Gastroenterology and Hepatology